Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic Latanoprost: An Equivalent Comparison Open-labelled Study
TCTR20180115001Not yet recruiting
- Sponsor
- Bausch + Lomb
- Start
- May 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of latanoprost in Glaucoma and ocular hypertension (2 arms), sponsored by Bausch + Lomb. Planned start May 2018; status: not yet recruiting.
02
Drugs
latanoprost
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on TCTR20180115001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180115001.